APO Research
Talk to an analyst

APO RESEARCH · REPORT

Felodipine Sustained-Release Tablet

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Felodipine Sustained-Release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025180 pages

Choose your research edition.

Industry ResearchFelodipine Sustained-Release Tablet Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Felodipine Sustained-Release Tablet Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Felodipine Sustained-Release Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Felodipine Sustained-Release Tablet Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Felodipine Sustained-Release Tablet Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Felodipine Sustained-Release Tablet market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Felodipine Sustained-Release Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Felodipine Sustained-Release Tablet include SHANXI KANGBO BIOLOGICAL PRODUCT, Sandoz, NanJing Easeheal Phaemaecutical, Mylan, Lifeon, Changzhou Siyao Pharmaceutical and Astrazeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Felodipine Sustained-Release Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Felodipine Sustained-Release Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Felodipine Sustained-Release Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Felodipine Sustained-Release Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Felodipine Sustained-Release Tablet Segment by Company

SHANXI KANGBO BIOLOGICAL PRODUCT

Sandoz

NanJing Easeheal Phaemaecutical

Mylan

Lifeon

Changzhou Siyao Pharmaceutical

Astrazeneca

Felodipine Sustained-Release Tablet Segment by Type

2.5mg Per Tablet

5mg Per Tablet

Others

Felodipine Sustained-Release Tablet Segment by Application

Treat High Blood Pressure

Relieve Angina

Others

Felodipine Sustained-Release Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Felodipine Sustained-Release Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Felodipine Sustained-Release Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Felodipine Sustained-Release Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Felodipine Sustained-Release Tablet market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Felodipine Sustained-Release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Felodipine Sustained-Release Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Felodipine Sustained-Release Tablet Industry Trends Table 2. Felodipine Sustained-Release Tablet Industry Drivers Table 3. Felodipine Sustained-Release Tablet Industry Opportunities and Challenges Table 4. Felodipine Sustained-Release Tablet Industry Restraints Table 5. Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Felodipine Sustained-Release Tablet Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers Table 9. Global Felodipine Sustained-Release Tablet Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Felodipine Sustained-Release Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Felodipine Sustained-Release Tablet Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Felodipine Sustained-Release Tablet Manufacturers, Product Type & Application Table 13. Global Felodipine Sustained-Release Tablet Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Felodipine Sustained-Release Tablet by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2.5mg Per Tablet Table 17. Major Manufacturers of 5mg Per Tablet Table 18. Major Manufacturers of Others Table 19. Global Felodipine Sustained-Release Tablet Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Felodipine Sustained-Release Tablet Sales by Type (2021-2026) & (K Units) Table 21. Global Felodipine Sustained-Release Tablet Sales by Type (2027-2032) & (K Units) Table 22. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2026) Table 23. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2027-2032) Table 24. Global Felodipine Sustained-Release Tablet Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Felodipine Sustained-Release Tablet Revenue by Type (2021-2026) & (K Units) Table 26. Global Felodipine Sustained-Release Tablet Revenue by Type (2027-2032) & (K Units) Table 27. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2026) Table 28. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Treat High Blood Pressure Table 30. Major Manufacturers of Relieve Angina Table 31. Major Manufacturers of Others Table 32. Global Felodipine Sustained-Release Tablet Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Felodipine Sustained-Release Tablet Sales by Application (2021-2026) & (K Units) Table 34. Global Felodipine Sustained-Release Tablet Sales by Application (2027-2032) & (K Units) Table 35. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2026) Table 36. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2027-2032) Table 37. Global Felodipine Sustained-Release Tablet Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Felodipine Sustained-Release Tablet Revenue by Application (2021-2026) & (K Units) Table 39. Global Felodipine Sustained-Release Tablet Revenue by Application (2027-2032) & (K Units) Table 40. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2026) Table 41. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2027-2032) Table 42. Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026) & (K Units) Table 44. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2021-2026) Table 45. Global Felodipine Sustained-Release Tablet Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Felodipine Sustained-Release Tablet Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 49. North America Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 50. Europe Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 52. Europe Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2027-2032) & (K Units) Table 59. Global Felodipine Sustained-Release Tablet Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Felodipine Sustained-Release Tablet Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Felodipine Sustained-Release Tablet Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2021-2026) Table 63. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2027-2032) Table 64. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information Table 65. SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview Table 66. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio Table 68. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Development Table 69. Sandoz Company Information Table 70. Sandoz Business Overview Table 71. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sandoz Felodipine Sustained-Release Tablet Product Portfolio Table 73. Sandoz Recent Development Table 74. NanJing Easeheal Phaemaecutical Company Information Table 75. NanJing Easeheal Phaemaecutical Business Overview Table 76. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio Table 78. NanJing Easeheal Phaemaecutical Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Mylan Felodipine Sustained-Release Tablet Product Portfolio Table 83. Mylan Recent Development Table 84. Lifeon Company Information Table 85. Lifeon Business Overview Table 86. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Lifeon Felodipine Sustained-Release Tablet Product Portfolio Table 88. Lifeon Recent Development Table 89. Changzhou Siyao Pharmaceutical Company Information Table 90. Changzhou Siyao Pharmaceutical Business Overview Table 91. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio Table 93. Changzhou Siyao Pharmaceutical Recent Development Table 94. Astrazeneca Company Information Table 95. Astrazeneca Business Overview Table 96. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio Table 98. Astrazeneca Recent Development Table 99. Key Raw Materials Table 100. Raw Materials Key Suppliers Table 101. Felodipine Sustained-Release Tablet Distributors List Table 102. Felodipine Sustained-Release Tablet Customers List Table 103. Research Programs/Design for This Report Table 104. Authors List of This Report Table 105. Secondary Sources Table 106. Primary Sources List of Figures Figure 1. Felodipine Sustained-Release Tablet Product Image Figure 2. Global Felodipine Sustained-Release Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Felodipine Sustained-Release Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Felodipine Sustained-Release Tablet Sales (2021-2032) & (K Units) Figure 5. Global Felodipine Sustained-Release Tablet Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Felodipine Sustained-Release Tablet Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2.5mg Per Tablet Image Figure 9. 5mg Per Tablet Image Figure 10. Others Image Figure 11. Global Felodipine Sustained-Release Tablet Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Felodipine Sustained-Release Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2032) Figure 14. Global Felodipine Sustained-Release Tablet Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Felodipine Sustained-Release Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2032) Figure 17. Treat High Blood Pressure Image Figure 18. Relieve Angina Image Figure 19. Others Image Figure 20. Global Felodipine Sustained-Release Tablet Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Felodipine Sustained-Release Tablet Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2032) Figure 23. Global Felodipine Sustained-Release Tablet Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Felodipine Sustained-Release Tablet Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2032) Figure 26. North America Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2032) Figure 28. U.S. Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2032) Figure 33. Germany Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2032) Figure 40. China Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2021-2032) Figure 48. Brazil Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Felodipine Sustained-Release Tablet Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Felodipine Sustained-Release Tablet Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Figure 59. North America Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Figure 61. Europe Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Felodipine Sustained-Release Tablet Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Felodipine Sustained-Release Tablet Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Felodipine Sustained-Release Tablet Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2.5mg Per Tablet
  • 5mg Per Tablet
  • Others
Applications
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Companies covered
  • SHANXI KANGBO BIOLOGICAL PRODUCT
  • Sandoz
  • NanJing Easeheal Phaemaecutical
  • Mylan
  • Lifeon
  • Changzhou Siyao Pharmaceutical
  • Astrazeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Felodipine Sustained-Release Tablet Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Felodipine Sustained-Release Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Felodipine Sustained-Release Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Felodipine Sustained-Release Tablet Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Felodipine Sustained-Release Tablet Market Dynamics
  1. 2.1 Felodipine Sustained-Release Tablet Industry Trends
  2. 2.2 Felodipine Sustained-Release Tablet Industry Drivers
  3. 2.3 Felodipine Sustained-Release Tablet Industry Opportunities and Challenges
  4. 2.4 Felodipine Sustained-Release Tablet Industry Restraints
3 Felodipine Sustained-Release Tablet Market by Manufacturers
  1. 3.1 Global Felodipine Sustained-Release Tablet Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Felodipine Sustained-Release Tablet Sales by Manufacturers (2021-2026)
  3. 3.3 Global Felodipine Sustained-Release Tablet Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Felodipine Sustained-Release Tablet Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Felodipine Sustained-Release Tablet Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Felodipine Sustained-Release Tablet Manufacturers, Product Type & Application
  7. 3.7 Global Felodipine Sustained-Release Tablet Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Felodipine Sustained-Release Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Felodipine Sustained-Release Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Felodipine Sustained-Release Tablet Tier 1, Tier 2, and Tier 3
4 Felodipine Sustained-Release Tablet Market by Type
  1. 4.1 Felodipine Sustained-Release Tablet Type Introduction
  2. 4.1.1 2.5mg Per Tablet
  3. 4.1.2 5mg Per Tablet
  4. 4.1.3 Others
  5. 4.2 Global Felodipine Sustained-Release Tablet Sales by Type
  6. 4.2.1 Global Felodipine Sustained-Release Tablet Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Felodipine Sustained-Release Tablet Sales by Type (2021-2032)
  8. 4.2.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2021-2032)
  9. 4.3 Global Felodipine Sustained-Release Tablet Revenue by Type
  10. 4.3.1 Global Felodipine Sustained-Release Tablet Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2021-2032)
  12. 4.3.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2021-2032)
5 Felodipine Sustained-Release Tablet Market by Application
  1. 5.1 Felodipine Sustained-Release Tablet Application Introduction
  2. 5.1.1 Treat High Blood Pressure
  3. 5.1.2 Relieve Angina
  4. 5.1.3 Others
  5. 5.2 Global Felodipine Sustained-Release Tablet Sales by Application
  6. 5.2.1 Global Felodipine Sustained-Release Tablet Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Felodipine Sustained-Release Tablet Sales by Application (2021-2032)
  8. 5.2.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2021-2032)
  9. 5.3 Global Felodipine Sustained-Release Tablet Revenue by Application
  10. 5.3.1 Global Felodipine Sustained-Release Tablet Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2021-2032)
  12. 5.3.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2021-2032)
6 Global Felodipine Sustained-Release Tablet Sales by Region
  1. 6.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Felodipine Sustained-Release Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Felodipine Sustained-Release Tablet Sales by Region (2021-2026)
  4. 6.2.2 Global Felodipine Sustained-Release Tablet Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Felodipine Sustained-Release Tablet Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Felodipine Sustained-Release Tablet Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Felodipine Sustained-Release Tablet Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Felodipine Sustained-Release Tablet Revenue by Region
  1. 7.1 Global Felodipine Sustained-Release Tablet Revenue by Region
  2. 7.1.1 Global Felodipine Sustained-Release Tablet Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Felodipine Sustained-Release Tablet Revenue by Region (2021-2026)
  4. 7.1.3 Global Felodipine Sustained-Release Tablet Revenue by Region (2027-2032)
  5. 7.1.4 Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Felodipine Sustained-Release Tablet Revenue (2021-2032)
  8. 7.2.2 North America Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Felodipine Sustained-Release Tablet Revenue (2021-2032)
  11. 7.3.2 Europe Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Felodipine Sustained-Release Tablet Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Felodipine Sustained-Release Tablet Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Felodipine Sustained-Release Tablet Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 SHANXI KANGBO BIOLOGICAL PRODUCT
  2. 8.1.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
  3. 8.1.2 SHANXI KANGBO BIOLOGICAL PRODUCT Business Overview
  4. 8.1.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio
  6. 8.1.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments
  7. 8.2 Sandoz
  8. 8.2.1 Sandoz Company Information
  9. 8.2.2 Sandoz Business Overview
  10. 8.2.3 Sandoz Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio
  12. 8.2.5 Sandoz Recent Developments
  13. 8.3 NanJing Easeheal Phaemaecutical
  14. 8.3.1 NanJing Easeheal Phaemaecutical Company Information
  15. 8.3.2 NanJing Easeheal Phaemaecutical Business Overview
  16. 8.3.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio
  18. 8.3.5 NanJing Easeheal Phaemaecutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Lifeon
  26. 8.5.1 Lifeon Company Information
  27. 8.5.2 Lifeon Business Overview
  28. 8.5.3 Lifeon Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio
  30. 8.5.5 Lifeon Recent Developments
  31. 8.6 Changzhou Siyao Pharmaceutical
  32. 8.6.1 Changzhou Siyao Pharmaceutical Company Information
  33. 8.6.2 Changzhou Siyao Pharmaceutical Business Overview
  34. 8.6.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio
  36. 8.6.5 Changzhou Siyao Pharmaceutical Recent Developments
  37. 8.7 Astrazeneca
  38. 8.7.1 Astrazeneca Company Information
  39. 8.7.2 Astrazeneca Business Overview
  40. 8.7.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio
  42. 8.7.5 Astrazeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Felodipine Sustained-Release Tablet Value Chain Analysis
  2. 9.1.1 Felodipine Sustained-Release Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Felodipine Sustained-Release Tablet Production Mode & Process
  6. 9.2 Felodipine Sustained-Release Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Felodipine Sustained-Release Tablet Distributors
  9. 9.2.3 Felodipine Sustained-Release Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst